Laparoscopic gastrectomy for gastric cancer

Area of Science:

• Surgical Oncology
• Minimally Invasive Surgery
• Gastrointestinal Surgery

Background:

• Gastric cancer (GC) treatment focuses on tumor resection and lymph node dissection while minimizing patient morbidity and mortality.
• Optimizing quality of life is a key consideration in surgical management of GC.

Purpose of the Study:

• To evaluate the safety and efficacy of laparoscopic gastrectomy for gastric cancer.
• To assess outcomes and identify potential benefits of minimally invasive surgery for GC patients.

Main Methods:

• A cohort of 113 patients with gastric cancer underwent laparoscopic gastrectomy between 1993 and 2008.
• Procedures included total or subtotal gastrectomy with D2 lymphadenectomy, utilizing laparoscopic ultrasound for metastasis assessment.
• Reconstruction varied based on tumor location (Roux-en-Y or Billroth II).

Main Results:

• Laparoscopic gastrectomy was performed in 92 patients with a mean surgical time of 162 minutes and a 5.4% mortality rate.
• 18.5% of patients had unresectable tumors or distant metastases, undergoing palliative procedures.
• Conversion to open surgery was required in 7.6% of cases.

Conclusions:

• Laparoscopic gastrectomy is a safe and effective treatment for gastric cancer, offering benefits of minimally invasive surgery.
• Outcomes appear similar to conventional surgery, avoiding nontherapeutic laparotomies in advanced cases.
• Long-term survival data require further investigation through prospective comparative studies.